Background Image
Table of Contents Table of Contents
Previous Page  33 / 67 Next Page
Information
Show Menu
Previous Page 33 / 67 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 2, March/April 2015

AFRICA

79

Key messages

HIV infection is a multisystem disease with a diverse

clinical spectrum.

HIV-associated vasculopathy is a unique entity confined

mainly to young individuals.

The pathogenesis remains largely theoretical and entails

a complex interplay between inflammatory, opportunis-

tic infections and atherosclerotic components.

The key histopathological findings include leucocy-

toclastic vasculitis of the vasa vasora, fragmentation

of the internal elastic lamina, variable intimo-medial

calcification, fibromuscular hyperplasia and transmural

inflammation.

The availability of HAART has altered the natural histo-

ry of the disease profile, with atherosclerosis emerging as

a potentially ominous therapeutic challenge.

Patients are managed along standard vascular surgical

guidelines as universal management guidelines have not

reached consensus to date.

Long-term results of intervention are uncertain because

of suboptimal patient compliance.

The exact indications for endovascular intervention

require further study.

We thank Mrs M Moodley for administrative support, Dr Y Sing for photo-

graphic assistance, the Bioethics Committee of the University of KwaZulu-

Natal for ethical approval (Protocol BF208/11) and the Medical Education

Partnership Initiative (MEPI) for partial study funding.

References

1.

Bennet NJ, Gilroy SA, Bronze MS, Glatt A, Windle ML. HIV

disease. emedicine.medscape.com.2011

.http://emedicine.medscape.com/

article/211316-overview. Accessed December 23/2013.

2.

Busari O, Opadijo O, Adeyemi O. Cardiac diseases in HIV and AIDS.

Internet J Cardiol

2008;

5

(2): 1–13.

3.

Mulaudzi TV. HIV-associated vasculopathy.

CME

2009;

27

(7): 320–322.

4.

Robbs JV, Paruk N. Management of HIV vasculopathy – a South

African experience.

Eur J Vasc Endovasc Surg

2010;

39

(Suppl 1): S25–

S31.

5.

Joshi VV, Pawel B, Connor E,

et al

. Arteriopathy in children with

acquired immune deficiency syndrome.

Pediatr Pathol

1987;

7

(3):

261–275.

6.

Chetty R. Vasculitides associated with HIV infection.

J Clin Pathol

2001;

54

(4): 275-–278.

7.

Johnson RM, Barbarini G, Barbaro G. Kawasaki-like syndromes

and other vasculitic syndromes in HIV-infected patients.

AIDS

2003;

17

(Suppl 1): S7–S82.

8.

Naidoo NG, Beningfield SJ. Other manifestations of HIV vasculopathy.

S Afr J Surg

2009;

47

(2): 46–53.

9.

Patel N, Patel N, Khan T, Patel N, Espinoza LR. HIV infection and

clinical spectrum of associated vaculitides.

Curr Rheumatol Rep

2011;

13

: 506–512.

10. Stankovic K, Miailhes P, Bessis D, Ferry T, Broussolle C, Séve P.

Kawasaki-like syndromes in HIV-infected adults.

J Infect

2007;

55

(6):

488–494.

11. Woolgar JD, Robbs JV. Vascular surgical complications of the acquired

immunodeficiency syndrome.

Eur J Vasc Endovasc Surg

2002;

24

(6):

473–479.

12. Benjamin LA, Bryer A, Emsley HCA, Khoo S, Solomon T, Conner

MD. HIV infection and stroke: current perspectives and future direc-

tions.

Lancet Neurol

2012;

11

(10): 878–890.

13. Guillevin L, Cohen P. Management of virus-induced systemic vascu-

litides.

Curr Rheumatol Rep

2002;

4

(1): 60–66.

14. Monseuz JJ, Charniot JC, Escaut L,

et al

. HIV-associated vascular

diseases: structural and functional changes, clinical implications.

Int J

Cardiol

2009;

133

(3): 293–306.

15. Nieuwhof CMG, Damoiseaux J, Tervaert JWC. Successful treatment of

cerebral vasculitis in an HIV-positive patient with anti-CD25 treatment.

Ann Rheum Dis

2006;

65

(12): 1677–1678.

16. Mu H, Chai H, Lin PH, Yao Q, Chen C. Current update on

HIV-associated vascular disease and endothelial dysfunction.

World J

Surg

2007;

31

(4): 632–643.

17. Maggi P, Ingrassia F, D’Annunzio M. Endothelial inflammatory disease

and cardiovascular risk in HIV patients.

HAART Correlated Pathol

2008;

1

: 19–25.

18. Schecter AD, Berman AB, Yi L,

et al

. HIV envelope gp120 activates

human smooth muscle cells.

Proc Natl Acad Sci USA

2001;

98

(18):

10142–10147.

19. Eugenin EA, Morgello S, KlotmanME,

et al

. Human Immunodeficiency

Virus (HIV) infects human arterial smooth muscle cells in vivo and in

vitro. Implications for the pathogenesis of HIV-mediated vascular

disease.

Am J Pathol

2008;

172

(4): 1100–1111.

20. Gutierrez J, Glenn M, Isaacson RS, Marr AD, Mash D, Petito C.

Thinning of the arterial media layer as a possible preclinical stage in

HIV vasculopathy: a pilot study.

Stroke

2012;

43

(4): 1156–1158.

21. Tilson MD 3rd, Withers L. Arterial aneurysms in HIV patients: molecu-

lar mimicry versus direct infection?

Ann NY Acad Sci

2006;

1085

(Nov):

387–391.

22. Mulaudzi TV, Robbs JV, Pillay W,

et al

. Thrombectomy in HIV

related peripheral arterial thrombosis: a preliminary report.

Eur J Vasc

Endovasc Surg

2005;

30

(1): 102–106.

23. Pipitone N, Salvarani C. The role of infectious agents in the pathogen-

esis of vasculitis.

Best Pract Res Clin Rheumatol

2008;

22

(5): 897–911.

24. Du Pont JR, Bonavita JA, DiGiovanni RJ, Spector HB, Nelson SC.

Acquired immunodeficiency syndrome and mycotic abdominal aneu-

rysms: a new challenge? Report of a case.

J Vasc Surg

1989;

10

(3):

254–257.

25. Bayley AC. Surgical pathology of HIV infection: lessons from Africa.

Br

J Surg

1990;

77

(8): 863–868.

26. Heikkinen MA, Dake MD, Alsac J-M, Zarins CK. Multiple HIV-related

aneurysms: open and endovascular treatment.

J Endovasc Ther

2005;

12

(3): 405–410.

27. Kuskov SI. Arterial pseudoaneurysms as the initial clinical manifestita-

tion of HIV Infection (Abstract).

East Cent Afr J Surg

2006;

11

(1):

94–98.

28. Marks C, Kuskov S. Pattern of arterial aneurysms in acquired immuno-

deficiency disease.

World J Surg

1995;

19

(1): 127–132.

29. Nair R, Abdool-Carrim ATO, Chetty R, Robbs JV. Arterial aneurysms

in patients infected with human immunodeficiency virus: a distinct clin-

icopathology entity?

J Vasc Surg

1999;

29

(4): 600–607.

30. Nair R, Robbs JV, Naidoo NG. Spontaneous carotid artery aneurysms.

Br J Surg

2000;

87

(2): 186–190.

31. Nair R, Robbs JV, Naidoo NG, Woolgar J. Clinical Profile of HIV–

related aneurysms.

Eur J Vasc Endovasc Surg

2000;

20

(3): 235–240.

32. Woolgar JD, Ray R, Maharaj K, Robbs JV. Colour Doppler and grey

scale ultrasound features of HIV-related vascular aneurysms.

Br J

Radiol

2002;

75

(899): 884–888.